NEW YORK, NY
Allocation by class
Portfolio Concentration
Top 3 weight
31.2%
Top 10 weight
70.2%
Voting Authority Distribution
Total shares with voting rights: 48.38M
Full voting authority
48.38M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 918.07K | SH | $58.71M 11.52% | 918.07K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.98M | SH | $55.83M 10.95% | 2.98M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.38M | SH | $44.66M 8.76% | 1.38M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 6.39M | SH | $44.23M 8.68% | 6.39M | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 1.35M | SH | $35.71M 7.01% | 1.35M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 354.82K | SH | $34.59M 6.79% | 354.82K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 543.88K | SH | $28.50M 5.59% | 543.88K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.45M | SH | $21.27M 4.17% | 3.45M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 306.05K | SH | $17.79M 3.49% | 306.05K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 329.01K | SH | $16.70M 3.28% | 329.01K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $15.87M 3.11% | 1.09M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 3.69M | SH | $12.60M 2.47% | 3.69M | 0.00 | 0.00 |
INFLARX NVSOLE | COM | 5.35M | SH | $11.99M 2.35% | 5.35M | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 432.04K | SH | $11.21M 2.20% | 432.04K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 392.57K | SH | $11.05M 2.17% | 392.57K | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 4.06M | SH | $9.94M 1.95% | 4.06M | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 1.66M | SH | $9.19M 1.80% | 1.66M | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 2.20M | SH | $8.57M 1.68% | 2.20M | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 1.66M | SH | $8.04M 1.58% | 1.66M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 422.54K | SH | $7.74M 1.52% | 422.54K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.58M | SH | $7.27M 1.43% | 3.58M | 0.00 | 0.00 |
RESEARCH ALLIANCE CORP IIISOLE | ORD SHS CL A | 500K | SH | $5.35M 1.05% | 500K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIISOLE | USD CL A ORD SHS | 500K | SH | $5.32M 1.04% | 500K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 279.11K | SH | $5.30M 1.04% | 279.11K | 0.00 | 0.00 |
ACHIEVE LIFE SCIENCE INCSOLE | COM | 736.64K | SH | $4.81M 0.94% | 736.64K | 0.00 | 0.00 |